Bayer Market Cap 2006-2019 | BAYRY

Bayer market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bayer market cap as of February 20, 2020 is $75.46B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $75.462B $46.752B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.914B 17.09
Roche Holding AG (RHHBY) Switzerland $300.375B 0.00
Novartis AG (NVS) Switzerland $220.677B 18.38
Merck (MRK) United States $210.018B 15.89
Pfizer (PFE) United States $198.398B 12.15
Novo Nordisk (NVO) Denmark $150.392B 25.82
AbbVie (ABBV) United States $139.349B 10.54
Eli Lilly (LLY) United States $135.806B 23.51
AstraZeneca (AZN) United Kingdom $128.407B 27.65
Sanofi (SNY) France $127.085B 15.10
GlaxoSmithKline (GSK) United Kingdom $106.698B 13.53
Bristol-Myers Squibb (BMY) United States $106.180B 13.95
H Lundbeck (HLUYY) Denmark $7.744B 13.45